NCT03862859 - The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis | Biotech Hunter

Enrollment

718

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Atrial Fibrillation and FlutterStrokeMajor BleedEnd-stage Renal Disease

Interventions

DRUG

Warfarin

Dose adjusted Warfarin targeting an international normalized ratio of 2-3.

Trial Locations (13)

2100

RECRUITING

Department of Nephrology, Copenhagen University Hospital Rigshospitalet, Copenhagen

2730

RECRUITING

Department of Nephrology, Herlev Hospital, Herlev

3400

RECRUITING

Department of nephrology, Nordsjaellands Hospital, Hillerød

3700

RECRUITING

Bornholms Hospital, Rønne

4000

RECRUITING

Zealand University Hospital, Roskilde

4300

RECRUITING

Holbaek Hospital, Holbæk

6400

RECRUITING

Hospital Sønderjylland, Sønderborg

6700

RECRUITING

Esbjerg and Grindsted Hospital, Esbjerg

7500

RECRUITING

Holstebro Hospital, Holstebro

8200

RECRUITING

Aarhus University Hospital, Aarhus

8800

RECRUITING

Viborg Regional Hospital, Viborg

9100

RECRUITING

Aalborg University Hosptial, Aalborg

Unknown

RECRUITING

Lillebælt Hospital, Kolding